The accumulated evidence suggests that maintaining 2-HG levels or IDH1 mutations may not be essential for glioma growth, as the loss of 2-HG or mutant IDH1 expression alone is insufficient to prevent tumor propagation [116,117]. Here, IDH1 is linked to glioma.